Description |
EUR-1008 (Zentase) is a new, zero-overfill, highly-stable, porcine-derived, pancreatic enzyme replacement product (PEP) for the treatment of Exocrine Pancreatic Insufficiency (EPI). EPI results from various diseases such as cystic fibrosis (CF), chronic pancreatitis, pancreatic cancer, cytomegalovirus infection and HIV/AIDS. EPI can also result from surgical procedures, including open gastric bypass, extensive small bowel resection and pancreatectomy.
|
